Infant fish oil study

Phase 2

Completed

• Conditions: Allergic disease; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12606000281594
• Lead Sponsor: Prof Susan Prescott

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-07-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

1) maternal asthma or hayfever, and atopy confirmed by skin testing (to common allergens); and 2) maternal age

Exclusion Criteria

Infants will be excluded if: 1) their mother’s normal dietary intake exceeds 2 meals of fish per week 2) there are any significant pregnancy or neonatal complications including prematurity of < 36 weeks), or 3) parental smoking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Allergic sensitisation[Assessed at 1, 2.5 and 5 years of age];Allergic disease[Assessed at 1, 2.5 and 5 years of age]

Secondary Outcome Measures

Name	Time	Method
Effects on immune development[At 6 and 12 months of age.]